MetaboNews Masthead
Published in partnership between
TMIC and the Metabolomics Society

Issue 47 - July 2015


Online version of this newsletter:

Welcome to the forty-seventh issue of MetaboNews, a monthly newsletter published in partnership between The Metabolomics Innovation Centre (TMIC, and the international Metabolomics Society (, to keep metabolomics researchers and other professionals informed about new technologies, software, databases, events, job postings, conferences, training opportunities, interviews, publications, awards, and other newsworthy items concerning metabolomics. MetaboNews represents the one-stop-shop for the very latest and most critical news about the science of metabolomics. In this issue, we feature a Metabolomics Spotlight article, "GigaScience Pushes Metabolomics Open Data", and a metabolomics interview with Oliver Jones of RMIT University.

This issue of MetaboNews is supported by:

Metanomics Health
Chenomx -- Metabolite Discovery &
mzCloud Advanced Mass Spectral Database
Metanomics Health GmbH

Chenomx Inc.


Would you like to advertise your metabolomics hardware, software, products, and services to over 2,750 MetaboNews readers worldwide? We offer a variety of advertising options. Please consult the MetaboNews advertising brochure for details.

Free Subscriptions: Our subscriber list is managed using Mailman, the GNU Mailing List Manager. To subscribe or unsubscribe, please visit
Newsletter Archive: Current and back issues of MetaboNews can be viewed from the newsletter archive (

Content Suggestions/Feedback: We always appreciate your feedback on how we can make this newsletter better (

Metabolomics Society Logo

Metabolomics Society News


11th Annual International Conference of the Metabolomics Society
Location: San Francisco, USA
Dates: June 29 - July 2, 2015

This year’s Metabolomics conference in San Francisco promises to be the biggest ever. With 12 workshops and 21 oral sessions there will be something for everyone.

SAVE THE DATE: 12th Annual International Conference of the Metabolomics Society
We are excited to announce that the 2016 Metabolomics conference will be held in DUBLIN, IRELAND from 27th-30th June 2016.
Dublin was selected following a highly competitive bidding process. The local organising committee, chaired by Lorraine Brennan and Aifric O’Sullivan, presented an impressive conference proposal, and we look forward to an amazing conference in 2016.

Support for non-Society conferences and workshops
The Metabolomics Society provides small grants to support events that promote metabolomics. The funding may be used to provide student prizes, travel awards or catering for small events such as symposia, workshops, seminars and short-courses. The Society may also sponsor larger conferences where there is strategic opportunity to promote metabolomics science within other scientific disciplines.

In 2015 the Metabolomics Society will provide student/EMN travel awards for the following meetings. Please see the individual websites for eligibility and application information:
For more information, or to apply for funding for your event, see:


Early-career Members Network (EMN)
The EMN is dedicated to and run by early-career scientists who are members of the Metabolomics Society and are from academia, government, or industry. The network aims to provide a forum for metabolomics researchers at the start of their professional career.

EMN events in the RFMF meeting, 2015 (Lille, France)
The French Metabolomics and Fluxomics Network (RFMF) held its 9th annual conference meeting in the north of France, in Lille. For the first time, the EMN was present with two committee members aiming to reinforce the collaboration between the young scientists of the two communities. There was a poster with the EMN activities and an organized EMN lunch session consisting of an introduction talk by Dr. Agneta Kiss, a career advice presentation by Prof. Phillipe Schmitt-Kopplin, and a metabolomics tools and resources overview by Dr. Justin van der Hooft. The lunch session was well attended by more than 30 early career researchers and a number of senior researchers as well. The event was evaluated by a scoring sheet, which showed that the EMN lunch session met the attendees' expectations and was highly appreciated by the early-career scientists. This questionnaire also gives an overview of their fields of interest and expertise domains and could be used as starting point for the planning of future events. The RFMF also recently started an early career division and showed at the end of the conference a strong interest in working together with the EMN on aspects like information and expertise sharing and the organization of workshops dedicated to early career sessions during international conferences in France.

EMN webinar series
The Early Career Members’ Network Committee recently hosted its fourth webinar on June 12th, 2015, with a presentation by Dr. Christophe Junot (Laboratory for Drug Metabolism Studies, French). The webinar discussed high-resolution mass spectrometry based tools for metabolomics and lipidomics developed at the laboratory, and their relevance to the field of biomarker discovery for the diagnosis and follow-up of pathologies.
Our fourth webinar was free for all to attend, and we would like to thank all attendees who tuned in to our session and engaged in what was a dynamic questions segment afterwards. If you were unable to join in and are interested in the content of our third webinar, a recording has been made freely available on the Metabolomics Society website.

Please feel free to contact us via if you have any suggestions or comments regarding our planned activities this year (i.e., online webinars and workshops). If you think you have a great idea for a new activity we should organise then please do share with us; the EMN can only be a success with your support and ideas!


Industry Engagement Task Group
The Metabolomics Society sincerely appreciates the support of our Corporate Sponsors for the annual Metabolomics Society conference in San Francisco. Without the support of our sponsors, we would not be able to maintain low conference costs. Please see our sponsors here and here.

If your firm would like to be involved in other Society activities, including Metabolomics 2016 in Dublin, please contact Sherie Howell,


Australian & New Zealand Metabolomics Network (ANZMN)
The ANZMN is focusing on NMR metabolomics this month. First up, there are two opportunities that might interest Metabolomics researchers either in, or wishing to move to, Australia. The University of Western Australia is looking for both a senior lecturer ( and a senior research officer ( in NMR and both posts could include metabolomics research. Metabolomics and NMR will also feature at the Australian and New Zealand Society for Magnetic Resonance (ANZMAG) conference which will take place from the 29th November to the 3rd December 2015 in New Zealand—please see for abstract submission and general information. Finally, Mestrelab have just announced an iPad/Android app called Mnova Tablet that lets you process NMR spectra of any format on your tablet. See for all the details.


Metabolomics journal, Vol. 11, Issue 3, June 2015
See the latest issue of our journal at:

In addition to the many excellent research papers, this issue contains the following contributions on the Metabolomics Society pages:

Stay abreast of the latest metabolomics news via the Twitter feed on the front page of the website. Also you can follow us on Twitter: Metabolomics Society @MetabolomicsSoc and Metabolomics journal @Metabolomics. And you can visit us on Facebook.


Call for nominations for Directors of the Metabolomics Society
In the next three months, the Metabolomics Society will undertake the annual process of nominating and electing four members to serve on the Society’s Board of Directors. We strongly encourage all Society members to play a role in nominations and elections.
Please contribute to shaping the future of our Society by voting and playing an active role.

Tim Ebbels (Chair of Nominations Committee) & Ute Roessner (President)

Software Spotlight

Metabolomics Spotlight

GigaScience Logo

GigaScience Pushes Metabolomics Open Data

Feature article contributed by Rob L Davidson, Data Scientist, GigaScience—ORCID iD:

With MetaboLights soon to publish its 100th public dataset, it is encouraging to see the growing volumes of data in the public domain, but there is still a long way to go to get the metabolomics community to open up its data. Particularly for clinical and reference datasets, as well as less conventional applications. With the aim of incentivizing the release of more biological data into the public domain, this month, data publisher GigaScience published its first metabolomics datasets and Data Note description articles.

Bring your own data (BYOD) party
The first of these publications ( describes and releases data from 180 plasma samples from healthy maternal pregnancy (LC-MS spectra, 3 modalities). This data note was the first created during a ‘bring your own data’ (BYOD) party last August, hosted by Gigascience in collaboration with the ISA Team at the University of Oxford e-Research Centre as part of BBSRC UK-China partnering award (BB/J020265/1)—see MetaboNews Issue 36, Aug 2014.

The Data Note allowed the release of extra data that had been left out of the original article due to non-significant results—this data is still useful for the community and data-only articles are a useful way to get citable outputs from all of one's work. These publications also focus much more on detailed descriptions of the collection methods, including ISA-Tab supplemental files and detailed figures as seen in Figure 1.

Ultra-detailed description
            of data collection developed during BYOD party

Figure 1. Ultra-detailed description of data collection developed during BYOD party.

The data is in MetaboLights (MTBLS146) and also mirrored in their repository (

A picture is worth a thousand spectra
The second data note is the first publicly available mass-spectroscopy (MS) imaging dataset
(! Making up close to 100GB of data, this data note includes four 3D MALDI imaging MS datasets, consisting of millions of spectra from murine tissue, human tissue and microbial colony samples, and a 3D DESI imaging MS dataset from human colorectal adenocarcinoma tissue (Figure 2).

MS imaging examples

Figure 2. MS imaging examples (clockwise from top left): human oral squamous cell carcinoma, mouse pancreas, mouse kidney, DESI-acquired colorectal adenocarcinoma, and microbial colony time course.

The supporting data in GigaDB ( also includes novel Matlab code files for loading these larger than normal imzML format files, and GigaDB provides faster-than-ftp download via Aspera. This dataset is also stored in MetaboLights (MTBLS176) and the team there has produced a novel ISA specification for MS imaging data that will hopefully be adopted by the community as we strive for greater standards and interoperability.

Open up your data
These releases represent useful data for the community, for algorithm building and training, especially the 3D imaging data, which is a novel and exciting approach that needs community support for the development of tools and pipelines. GigaScience is pleased to support the MetaboLights repository with early data-release, mirroring, DOIs for citation tracking, analytics storage, and, of course, extra metadata via the Data Note article. 

GigaScience is seeking data and submissions for a new series on “Plant Metabolomics: approaches, applications, and challenges” (, edited by Ute Roessner and Ruth Welti.

Please note:
If you know of any metabolomics research programs, software, databases, statistical methods, meetings, workshops, or training sessions that we should feature in future issues of this newsletter, please email Ian Forsythe at

 MetaboInterview Icon


This section features interviews with prominent researchers in the field of metabolomics. The aim of these interviews is to shed light on metabolomics researchers around the world and give them an opportunity to share their metabolomics story. In this issue, we feature an interview with Oliver Jones.

Senior Lecturer in Analytical Chemistry, RMIT University, Melbourne, Australia
Oliver Jones


Dr Oliver (Oli) Jones is a senior lecturer in analytical chemistry at RMIT University in Melbourne, Australia. He obtained his PhD from Imperial College London in 2005, then worked as a postdoc in the department of Biochemistry at the University of Cambridge, and later as a lecturer in the School of Engineering and Computing Sciences at the University of Durham. Oli is currently president of Proteomics and Metabolomics Victoria and the Australian and New Zealand Metabolomics Network (for whom he writes a weekly newsletter); secretary of the Australian and New Zealand Society for Magnetic Resonance; a CI at the Australian Centre for Research on Separation Science and a member the Australian Academy of Science, National Committee for Chemistry. Aside from metabolomics, his group also conducts research in analytical methods and technologies, particularly in multidimensional chromatographic techniques, for a range of applications including environmental food and forensic chemistry. He is also deputy director of the RMIT Centre for Environmental Sustainability and Remediation and serves on the editorial board of the Journal of Environmental Immunology and Toxicology. He has 55 publications with a total of over 2300 citations and an h-index of 19.

Metabolomics Interview (MN, MetaboNews; OJ, Oliver Jones)

MN: How did you get involved in metabolomics?

OJ: By a slightly circuitous route. In 2005, I had just finished my PhD in environmental chemistry at Imperial College in London. I worked on the fate and behaviour of pharmaceutical compounds in wastewater. At the time there was a lot of interest in the fate of things such as ibuprofen and paracetamol that people take every day and which end up in sewage. I had come to the conclusion that individual compounds were most likely present at too low a concentration to have any effect but that the effects of mixtures of many pharmaceutical drugs might be a problem and were not really being looked at. I was searching ScienceDirect for methods or techniques that would allow me to pick up such subtle effects and came across a paper on metabolomics by Jules Griffin at Cambridge University, which explained how the approach could be used for environmental toxicology. I was really fascinated by the idea. A few months later, having passed my PhD viva exam, I was job hunting and saw an advert for a postdoc post in Jules' lab working on an environmental metabolomics project. They were looking for somebody who had experience in gas chromatography mass spectrometry and I had used that technique throughout my PhD. I also had an environmental background as well as a bachelors degree in biology, so it seemed like a really good fit (and who is going to turn down a chance to work at Cambridge)? I applied and got the job and it went from there.

MN: What are some of the most exciting aspects of your work in metabolomics?

OJ: Well I guess the most exciting part is the same as in any scientific field; the chance to continually do something new and to find out something nobody has ever seen before (and working with people from all over the world while doing so). In my time at Cambridge, we published the first metabolic profiles of several ecologically important species including the water flea Daphnia magna and the marine mussel Mytilus galloprovincialis. We also showed that metabolomic profiling of Caenorhabditis elegans has the potential to improve the safety assessment of new chemicals (and mixtures thereof), with increasing speed and accuracy, whilst using fewer resources and experimental (vertebrate) animals; that was quite exciting to be a part of. I also enjoy the chance to work with people in other omic sciences in integrated biology studies, which give us a more holistic overview of the system under study.

MN: What key metabolomics initiatives are you pursuing at your research centre or institute?

            fluorescent compoundsOJ:  Recently my group has focussed more on the analytical chemistry side of metabolomics, particularly separation science. We have been applying online two-dimension liquid chromatography (2DLC) methods to increase the number of metabolites we can pick up in single run for example (see MetaboNews January 2015— So far we have applied 2DLC to the untargeted analysis of mushrooms and the targeted analysis of cannabinoids in hemp. This work won an outstanding investigator award at the Metabolomics Society meeting in Japan last year—so hopefully I am doing something right. My group has recently become part of the Australian Centre for Research on Separation Science (ACROSS), which was a real honour and has been very productive. My most recent project is based on using some highly fluorescent compounds (see image), originally developed for use in solar cells as tags for the analysis of fatty acids at low concentrations via HPLC, rather than the more common FAME analysis via GC-FID.

MN: What is happening in your country in terms of metabolomics?

ANZMN LogoOJ: Although I was born and bred in the UK, I now call Australia home and there is a lot of great work going on here. Metabolomics Australia has been going for some time now and is well known. In Victoria, we also have Proteomics and Metabolomics Victoria and, since 2012, the Australian and New Zealand Metabolomics Network (ANZMN), which recently became an official affiliate of the International Metabolomics Society. We publish a weekly metabolomics e-newsletter and the team has helped organise a series of well-respected (and well-attended) workshops and training sessions. We also get a lot of support from most of the major instrument vendors, who all see metabolomics as a growth area so I think the field will continue to grow in Australia for a while yet.

MN: How do you see your work in metabolomics being applied today or in the future?

OJ: In the short term, I very much hope to see more applications of multidimensional chromatography in metabolomics to increase the number of metabolites we can see in a single run. In the longer term, I think metabolomics could make a real difference to risk assessment. For example, the work we did on mixture effects in environmental toxicology showed that this issue should be considered in chemical risk assessment (and that metabolomics could help assess such mixture effects); a later project at Cambridge, funded by the UK Food Standards Agency, helped improve our understanding of the risks to humans of exposure to mixtures of pesticides in food.

MN: As you see it, what are metabolomics' greatest strengths?

OJ: I think the greatest strengths of metabolomics are its sensitivity and its wide applicability. We can routinely pick up incredibly small changes in metabolism and work out what caused them and, although medical metabolomics makes the most of the headlines, the technique has made contributions to a huge number of areas. Notwithstanding the environmental applications, I have already discussed how metabolomics has been used in studies on drug toxicity, functional genomics, microbiology, nutrition, plant science and toxicology to name just a few. The other strength of metabolomics is the fantastically clever and dedicated people who are part of it. For example, it is great to see so many new computer databases and software that pop up on a fairly regular basis, that are of a very high standard and often open source. It is no wonder that the Metabolomics Society conference last year had a whole session on software development.

MN: What do you see as the greatest barriers for metabolomics?

OJ: I think the greatest strength of metabolomics (its sensitivity) is also potentially one of its greatest weaknesses. Advanced software also makes it very simple to apply very powerful statistical tools without really understanding what they do or what the results mean. As a result, it is still all too easy to do a poorly designed experiment, find separation between two or more sample groups (often with low n numbers), and claim it is useful data. I think a greater focus on education in bioinformatics will help address this issue in the future though.

MN: What improvements, technological or otherwise, need to take place for metabolomics to really take off?

OJ: Well, given the sheer number of papers published on metabolomics today, I think one could argue that the field has already 'taken off'. Nevertheless, one thing that I think will really drive advances will be the miniaturisation of analytical instrumentation. For instance back in the 1980s mass spectrometers were the size of a small room and required a computer almost as big, as well as highly trained staff to run them, and, as such, were the preserve of the few. Once mass specs were small and robust enough to be used routinely in the lab, however, the use and applications of mass spectrometry expanded rapidly. The new wave of benchtop NMR spectrometers is a great step in the direction of smaller instruments, and applications of this technique have already started to take off but I hope this is just the start. Imagine if you had an LC the size of a computer chip or lab slide (already being worked on at ACROSS), and/or a mass spectrometer robust enough for you to transport in (and perhaps even power from) your car, and as easy to operate as your smartphone? The potential this would have for metabolomic analysis of samples from huge numbers of people could drive some incredible work in the health and medical sciences as well as a range of other fields. It would be nice to see that in my lifetime.

MN: How does the future look in terms of funding for metabolomics?

OJ: I guess that depends on where you are in the world. In Australia, the current government does not seem too keen on science funding overall but Metabolomics itself has been very well funded in the past, probably better than almost anywhere else in fact. Metabolomics Australia has nodes all around the country and has produced some really excellent data and data management techniques. I suspect medical (and to a lesser extent agricultural) science will get the lion’s share of research money in the near future, but as metabolomics fits into both of these areas, we will see how we go.

There are encouraging signs further afield as well, for example, the National Phenome Centre in the UK, and the recent $3 million investment by the Canadian government into the University of Alberta’s metabolomics technology demonstration centre. And who knows? Since our Prime Minister (Tony Abbot) seems to get on well with his Canadian counterpart (Stephen Harper), perhaps we can convince him to make a similar investment.

MN: What role can metabolomics standards play?

OJ: I think standards have an extremely important role to play in metabolomics. As we all know, metabolomics is a very sensitive for picking up small changes but that can be a double-edged sword in that even small changes to the experimental method can affect the results. With more and more researchers using metabolomics, it is really vital to create community standards to facilitate data comparison, exchange and authentication. It is standard practice in most of the other omic sciences but does not seem to have really caught hold in metabolomics yet, despite being discussed many times over the years. I was lucky enough to be involved in drafting the suggested standard reporting requirements for biological samples in metabolomics experiments in the environmental context back in 2007 and it is nice to see initiatives such as the COSMOS (COordination Of Standards In MetabOlomicS) project working in this area. It has also been great to see the Metabolomics Society pushing for all metabolomics data to be put in public repositories such as the MetaboLights database. I hope that in time all journal editors will require authors of any metabolomics-related paper to do this, no matter what the application.

MN: Do you have any other comments that you wish to share about metabolomics?

OJ: Any scientific field is only as strong as the people who work in it and metabolomics has some of the best. I'd particularly like to thank Jules Griffin for giving me a chance ten years ago, and Metabolomics Society president Ute Roessner and the ANZMN and PMV teams for their support since I arrived in Australia. Thanks are also due to Industry supporters including (but not limited to) Tom Hennessy from Agilent, Matt Nussio and Shaw Feng Ong from Perkin Elmer, Mustafa Ayhan from AB SCIEX, Steven Ramsay from Thermo Fisher, and Dave Shock and Hung Luu from Phenomenex. Thank you also to the good people of Victoria, who presently pay me for both conducting research and the very great privilege of teaching their children about analytical chemistry and metabolomics.

Please note: We are open to suggestions for our MetaboInterviews section. Please send suggestions for future interview candidates to Ian Forsythe at

Metabolomics Current Contents

Metabolomics Current Contents

This section of MetaboNews is supported by:
LECO Corporation


Metabolomics Events

19-22 Jul 2015

ANZSMS25/AOMSC6: The 25th Conference of the Australian and New Zealand Society for Mass Spectrometry (ANZSMS) and the 6th Conference of the Asia and Oceania Society for Mass Spectrometry Conference (AOMSC)
Venue: Brisbane, Australia

ANZSMS was formed in 1970 and has as its mission to bring together the broad spectrum of scientists who work in the field of mass spectrometry and its allied disciplines. In keeping with this mission, ANZSMS25 will promote the science of mass spectrometry by facilitating interaction with local, regional and international leaders from all areas of science in which mass spectrometry plays a central role. We are delighted to be holding ANZSMS25 as a joint meeting with our sister societies in Asia and Oceania. This will be the 6th time the AOMSC has been held and the first in the southern hemisphere and provides a unique opportunity to engage with the world-class science and scientists from our own region. We hope you will join us in Brisbane for this exciting showcase of mass spectrometric research."

The 2015 conference will include a Metabolomics session sponsored by the Metabolomics Society, featuring Prof Lloyd Sumner. Travel awards are available for Early Career member of the Metabolomics Society and the Australia New Zealand Metabolomics Network (

For further details, visit

26-28 Aug 2015

Mountain Village Science Series Bio & Data 2015
Venue: Karlova Studánka, Czech Republic

Aimed at bioinformaticians and chemometricians, this event is designed around problem-driven discussions which aim to identify and address the leading challenges currently facing the field of omics-centred chemometrics.

The opening lecture will be delivered by Miloš V. Novotný, Director of the Institute for Pheromone Research, Indiana University. Other speakers include Tim Stratton, Reza Salek, Ron Wevers, David Broadhurst and Lennart Eriksson.

Abstract submission for both oral and poster presentation is now open, full details of which can be seen here. Please note the closing date for submitting abstracts is Monday 1st June 2015 for oral presentations and Wednesday 1st July 2015 for posters.

To register, visit the website at

14-17 Sep 2015

36th BMSS Annual Meeting 15th-17th September 2015
BMSS Introduction to Mass Spectrometry Course 14th & 15th September 2015

Venue: University of Birmingham – Edgbaston

The 2015 BMSS Annual Meeting will take place at the vibrant city centre campus of the University of Birmingham, from Tuesday September 15th to Thursday September 17th. This year's meeting will have a strong emphasis on connections, featuring sessions from the individual Special Interest Groups (SIG's), joint sessions with BSPR and the Metabolomics Society in addition to more general main sessions, designed to attract a wide audience and range of submitted abstracts. The Maccoll Lecture (at the conference start, on the evening of the 15th) will be delivered by Professor Ron Heeren, the Wednesday plenary Professor Brian Chait, closing with the Professor Ian Wright, principal investigator in the Rosetta space mission. Dr Zoltan Takats will speak in the joint session with the Metabolomics Society. There will be a full poster session, featuring the Barber/Bordoli prize awards. The meeting will also feature a full exhibition with involvement of over 30 industry partners

Online abstract submission for both oral and poster presentation is now available. Please note the closing date for submitting abstracts is Friday 22nd May 2015.

For more information, visit

21-25 Sep 2015

W4M Course 2015: Computational Metabolomics within the Galaxy Environment on the Online (W4M) Resource
Venue: ABiMS Bioinformatics Institute, Roscoff, France

The Worflow4Metabolomics Course 2015 (W4M 2015) will take place at the ABiMS bioinformatics Institute (Roscoff, France) on September 21-25, 2015. This one-week training session is intended for MS and NMR researchers wishing to learn the functionalities from the W4M resource. It will include an initiation to the Galaxy environment, followed by dedicated practical sessions covering the available modules for data preprocessing, statistical analysis, and annotation. Finally, a tutoring part will enable each participant to analyse his or her own dataset. Presentations will be given in French but course materials will be in English.

Program Schedule:
Practical Information:

Organizing Committee
Cécile Canlet, Christophe Caron, Franck Giacomoni, Yann Guitton, Gildas Le Corguillé, and Étienne Thévenot.

For further details, visit

7-9 Dec 2015

MetaboMeeting 2015
Venue: Robinson College, Cambridge, UK

SELECTBIO are delighted to announce that we are once again partnering with the Metabolic Profiling Forum (MPF) to host the Metabomeeting 2015. The MPF will focus on the conference program while SELECTBIO will take care of logistics, promotion and exhibition/sponsorship activities. We are expecting up to 270 attendees offering a unique opportunity to network with key researchers who are making innovative discoveries within this field.   We are also delighted to announce that this year the registration price includes a wonderful dinner reception which will be held on Tuesday 8th December in the Magnificent Kings College Dining Hall.

Agenda Topics
  • Advancing Biological Knowledge from Single Cells to Whole Organisms
  • Applying Metabolomics to Nutritional Support and Food Analysis
  • Clinical Development in Metabolomics
  • Enhancing Analytical Approaches in Metabolomics
  • Modelling and Data Analysis
  • New Developments in Plant Metabolomics
  • Next Generation Metabolomics - Where will the Revolution will Happen Next
  • Structure and Reporting of Metabolomics: Data to Knowledge
For further details, visit

Please note: If you know of any metabolomics lectures, meetings, workshops, or training sessions that we should feature in future issues of this newsletter, please email Ian Forsythe (
Metabolomics Jobs

Metabolomics Jobs

This is a resource for advertising positions in metabolomics. If you have a job you would like posted in this newsletter, please email Ian Forsythe ( Job postings will be carried for a maximum of four issues (eight weeks) unless the position is filled prior to that date.

Jobs Offered

Job Title Employer Location Posted Closes Source
Max Planck Institute
Munich, Germany 22-Jun-2015

Metabolomics Society Jobs
Position as PhD Research Fellow within the field of prostate cancer metabolism
Norwegian University of Science and Technology Trondheim, Norway 22-Jun-2015
Metabolomics Society Jobs
International Business Development Manager
BIOCRATES Life Sciences AG Innsbruck, Austria 19-Jun-2015
19-Jul-2015 Metabolomics Society Jobs
Business Development Manager East Coast
BIOCRATES Life Sciences AG Home office based, pref. East Coast 19-Jun-2015 19-Jul-2015 Metabolomics Society Jobs
Director, Marketing Metabolomics
Thermo Fisher Scientific San Jose, California, USA 18-Jun-2015
Until filled
Metabolomics Society Jobs
Three Tenure-Track Faculty Appointments
Institute of Chemistry, National Autonomous University of Mexico Coyoacan, Mexico 12-Jun-2015
Metabolomics Society Jobs
Mass Spectrometry Informatician
Agios Pharmaceuticals Cambridge, Massachusetts, USA 8-Jun-2015

Agios Pharmaceuticals
Postdoctoral Position, Metabolic Studies of Cancer Models
University of California, San Francisco San Francisco, California, USA 5-May-2015
Until filled
Metabolomics Society Jobs
Postdoc, Northwest Metabolomics Research Center
University of Washington Seattle, Washington, USA 17-Apr-2015
31-May-2015 or until filled
Metabolomics Society Jobs
Postdoc, Mitochondria and Metabolism Center University of Washington Seattle, Washington, USA 17-Apr-2015
31-May-2015 or until filled Metabolomics Society Jobs
Research Assistant I, Metabolomics Core Facility
Sanford-Burnham Medical
Research Institute
Orlando, Florida, USA 3-Mar-2015
Open until filled
Metabolomics Society Jobs
Postdoctoral Research Fellow, Fernandez Laboratory, School of Chemistry and Biochemistry
Georgia Institute of Technology
Atlanta, Georgia, USA 19-Feb-2015
Open until filled Georgia Institute of Technology

Jobs Wanted

This section is intended for very highly qualified individuals (e.g., lab managers, professors, directors, executives with extensive experience) who are seeking employment in metabolomics. We encourage these individuals to submit their position requests to Ian Forsythe ( Upon review, a limited number of job submissions will be selected for publication in the Jobs Wanted section.
  • There are currently no positions being advertised.

Free Subscription

To subscribe or unsubscribe, please visit Please forward this newsletter to any interested colleagues or collaborators. Send your comments and feedback about this newsletter to

Back issues of this newsletter can be viewed from the newsletter archive (